CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit
– This Version Removes the Use of ‘Presentation’ from the Prior-issued Headline – – Linea™ IVT Platform Delivers All The Benefits of Conventional IVT Without dsRNA Contamination – STONY BROOK,…
